Tyrogenex
Palm Beach Gardens, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MW
Michael WebbExecutive
JS
Joseph StraightExecutive
CL
Chris LiangNamed on SEC filing
SG
Sheridan G. SnyderNamed on SEC filing
DL
Dennis L. PalmgrenNamed on SEC filing
SD
Sheridan D. SnyderNamed on SEC filing
Board
TB
JI
John Irwin IIIBoard director
AG
Adam GoodfriendBoard director
VP
Vinzenz PloererBoard director
SS
Sheridan SnyderBoard director
CC
Cheryl CalhounBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$12.1M disclosed across 3 rounds · 2013–2016
▶$544KraisedFeb 2016 · 18 investors · BiotechnologyRule 506(b)
▶$544KraisedFeb 2016 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Todd BradyDirector
- Chris LiangExecutive Officer, Director
- Sheridan SnyderDirector
- Michael WebbExecutive Officer, Director
- John Irwin IIIDirector
- Adam GoodfriendDirector
- Vinzenz PloererDirector
- Cheryl CalhounDirector
- Joseph StraightExecutive Officer
- Offering amount
- $12M
- Amount sold
- $544K
- Sales commissions
- $24.5K
- Placement agents
- TAG Healthcare Advisors, LLC
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.2MraisedApr 2014 · 40 investors · BiotechnologyRule 506(b)
▶$8.2MraisedApr 2014 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dennis L. PalmgrenDirector
- Sheridan D. SnyderExecutive Officer
- Sheridan G. SnyderExecutive Officer, Director
- Chris LiangExecutive Officer, Director
- Offering amount
- $8.6M
- Amount sold
- $8.2M
- Minimum investment
- $11.3K
- Sales commissions
- $25.6K
- Placement agents
- The Alberleen Group LLC
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedApr 2014 · 38 investors · BiotechnologyRule 506(b)
▶$3.3MraisedApr 2014 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sheridan G. SnyderExecutive Officer, Director
- Dennis L. PalmgrenDirector
- Chris LiangExecutive Officer, Director
- Sheridan D. SnyderExecutive Officer
- Offering amount
- $3.6M
- Amount sold
- $3.3M
- Minimum investment
- $9K
- Sales commissions
- $124.2K
- Placement agents
- The Alberleen Group LLC
- First sale
- May 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Tyrogenex's investors?
- Tyrogenex's investors include Brace Pharma.
- How much funding has Tyrogenex raised?
- Tyrogenex has disclosed $12.1M raised across 3 rounds.
- Where is Tyrogenex headquartered?
- Tyrogenex is headquartered in Palm Beach Gardens, US.